Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma.
The global SARS-CoV-2 coronavirus pandemic continues to be devastating in many areas. Treatment options have been limited and convalescent donor plasma has been used by many centers to transfer passive neutralizing antibodies to patients with respiratory involvement. The results often vary by instit...
Main Authors: | Stacey L Fanning, Robert Korngold, Zheng Yang, Kira Goldgirsh, Steven Park, Joshua Zenreich, Melissa Baker, Phyllis McKiernan, Ming Tan, Bingsong Zhang, Michele L Donato, David S Perlin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-10-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1010025 |
Similar Items
-
Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
by: Stacey L. Fanning, et al.
Published: (2021-10-01) -
Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
by: Michele L. Donato, et al.
Published: (2021-03-01) -
Striking elevations in systemic and mucosal cytokine and chemokine levels in acute HIV-1 infection
by: Stacey, A, et al.
Published: (2009) -
Effect of time and titer in convalescent plasma therapy for COVID-19
by: Paola de Candia, et al.
Published: (2021-08-01) -
OA011-04. Striking elevations in systemic and mucosal cytokine and chemokine levels in acute HIV-1 infection
by: Denny T, et al.
Published: (2009-10-01)